677PAfatinib in combination with cisplatin and 5-fluorouracil (5-FU) as first line treatment in inoperable gastric and gastro-esophageal junction (GEJ) cancer: A phase II study by the Hellenic Cooperative Oncology Group. (23rd October 2018) - Makatsoris, T; Samantas, E; Manousou, K; Karavasilis, V; Aravantinos, G; Tryfonopoulos, D; Psyrri, A; Pectasides, D G; Pazarli, E; Petraki, C; Tsipoura, A; Kaklamanos, I G; et al.